Showing results (91-100 of 1,494) with videos related to
Sort By:
Pageof 150
Journal of Oral Rehabilitation|September 15, 2005
The aesthetics of all-ceramic veneered and monolithic CAD/CAM crownsM Herrguth, M Wichmann, S ReichCytokines, Cellular & Molecular Therapy|January 21, 2000
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartmentsL Weiss, S Reich, S SlavinJournal of Optimization Theory and Applications|April 15, 2011
The Subgradient Extragradient Method for Solving Variational Inequalities in Hilbert SpaceY Censor, A Gibali, S ReichThe Annals of Otology, Rhinology, and Laryngology|May 1, 1995
Upper airway obstruction in Sturge-Weber and Klippel-Trenaunay-Weber syndromesD S Reich, B J WiatrakArthroplasty Today|March 23, 2018
A nonsurgical protocol for management of postarthroplasty wound drainageMichael S Reich, Kace A EzzetAnnals of Plastic Surgery|May 1, 1991
A comparison of speech results after the pharyngeal flap and the dynamic sphincteroplasty proceduresJ M Pensler, D S ReichJournal of Bacteriology|February 1, 1990
Modification of dinitrogenase reductase in the cyanobacterium Anabaena variabilis due to C starvation and ammoniaA Ernst, S Reich, P BögerCytokines, Cellular & Molecular Therapy|January 21, 2000
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemiaL Weiss, S Reich, S SlavinJournal of Nanoscience and Nanotechnology|June 24, 2006
Modelling the nucleation and chirality selection of carbon nanotubesL Li, S Reich, J RobertsonCancer Investigation|January 1, 1992
Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapyL Weiss, S Reich, S SlavinPageof 150